By the GLP Chart editors. How we check. How we make money. Some visit links earn us a commission.

Reporting

Novo Nordisk, the maker of Ozempic and Wegovy, will go by Novo

Published

Novo Nordisk A/S stays the legal name, the Danish company said on September 14, 2026.

Two cash programs to check.

No insurance needed.

  1. Collective logoCollective$76 a month, with the $199 yearly membership averaged insemaglutide, compounded, not FDA-approved
    Check price →
  2. SnagRx logoSnagRx$99 a monthBilled monthly. The 12-month plan is $69 a month, billed as $828 up front.semaglutide, compounded, not FDA-approved
    Check price →SnagRx's homepage shows its 12-month prepaid prices first

Novo paired the name with a slogan, "Lasting Health Starts Now," and an updated visual identity that includes the Apis bull logo. The company also set out four workplace principles under the name "The Novo Way": customer obsession, competitiveness, clarity, and care and integrity.

The announcement does not mention Ozempic, Wegovy or any price. No price on the chart changed with it.

Mike Doustdar, Novo's president and chief executive, said the new brand and culture will improve how the company operates and competes.

Novo will present its updated corporate strategy at a Capital Markets Day in London on September 21, 2026.

What Wegovy costs without insurance and what Ozempic costs set the cash prices at Novo's NovoCare Pharmacy beside the telehealth programs.

The source

“‘Novo’ will be used as the name of the company day-to-day, while Novo Nordisk A/S remains the legal global company name.”

Novo Nordisk enters next chapter to bring better health to more people, supported by ‘Novo’ rebrand and updated corporate culture, Novo Nordisk, September 14, 2026. Accessed September 14, 2026.

Why you can trust GLP Chart. Same scoring framework applied to every program, and payment never changes a score. We never remove unfavorable information at an advertiser's request. Pricing is pulled from each program's public-facing page every week.